[Federal Register: August 8, 2002 (Volume 67, Number 153)]
[Notices]               
[Page 51590-51591]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08au02-70]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Center for Complementary & Alternative Medicine; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Council for Complementary and Alternative Medicine (NACCAM).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussion could disclose confidential

[[Page 51591]]

trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Complementary 
and Alternative Medicine.
    Date: August 26, 2002.
    Closed: 8:30 a.m. to 12:15 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Open: 1:15 p.m. to adjournment.
    Agenda: The agenda includes Opening Remarks by Director, NCCAM, 
NIH Director's Remarks by Director, NIH, Report on NCCAM Research 
Centers Program, Concept Review: Research Centers, CAM Research 
Education, Clinical Evaluation of CAM Products, PC SPES Update, and 
other business of the Council.
    Place: Neuroscience Conference Center, 6001 Executive Boulevard, 
Conference Rooms C and D, Rockville, MD 20852.
    Contact Person: Jane F. Kinsel, Ph.D., Executive Secretary, 
National Center for Complementary and Alternative Medicine, National 
Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 
20892. 301/402-7269.
    The public comments session is scheduled from 5:45-6 p.m. Each 
speaker will be permitted 5 minutes for their presentation. Interested 
individuals and representatives of organizations are requested to 
notify Dr. Jane Kinsel, National Center for Complementary and 
Alternative Medicine, NIH, 6707 Democracy Boulevard, Suite 401, 
Bethesda, Maryland 20892, 301-402-7269, Fax: 301-480-3519. Letters of 
intent to present comments, along with a brief description of the 
organization represented, should be received no later than 5 p.m. on 
August 16, 2002. Only one representative of an organization may present 
oral comments. Any person attending the meeting who does not request an 
opportunity to speak in advance of the meeting may be considered for 
oral presentation, if time permits, and at the discretion of the 
Chairperson. In addition, written comments may be submitted to Dr. Jane 
Kinsel at the address listed above up to ten calendar days (September 
10, 2002) following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by Dr. Jane Kinsel, Executive Secretary, NACCAM, 
National Institutes of Health, 6707 Democracy Boulevard, Suite 401, 
Bethesda, Maryland 20892, 301-402-7269, Fax 301-480-3519.

    Dated: August 2, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 02-20109 Filed 8-7-02; 8:45 am]
BILLING CODE 4140-01-M